Company intelligence / Profile preview

ACROBiosystems

Newark, Delaware, USAacrobiosystems.com ↗

Ownership: Public · 301080
Employees: ~700
Development stage: Commercial

Overview

ACROBiosystems supplies high-quality recombinant proteins, antibodies, assay kits and GMP-grade reagents that are widely used by the global biopharmaceutical industry to accelerate drug discovery through commercialization. Their products support cell/gene therapy manufacturing and diagnostic/vaccine development. They do not report clinical results as they are a tools provider rather than a therapeutic developer

Therapeutic areas: OtherOncologyImmunologyInfectious Diseases
Modalities: AntibodyRecombinant proteinAssay kitEnzymeCytokineCell therapy reagent
Industry: Chemicals & Materials

Partnerships

Collaborations with academic institutions such as University of Wisconsin–Madison College of Engineering for stem cell technology advancementpartnerships with pharmaceutical/biotech companies via supply agreements for reagents/tools.

Beyond the preview

Go deeper on ACROBiosystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACROBiosystems.

Explore the full profile